Dr. Jonathan Stine is a transplant hepatologist and Clinical Professor of Medicine at Penn State. As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD), he has authored more than 130 peer-reviewed papers, including multinational consensus guidelines for the American College of Sports Medicine and Exercise and Sports Science Australia, and has lectured across the United States and Europe. Dr. Stine has been the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases, American Cancer Society and National Institutes of Health. His research has been featured by various media outlets including ABC, the Associated Press, NPR, Yahoo and STAT News. Since 2023, he has been recognized by Stanford University as being among the World’s Top 2% Scientists.